What is the most recent earnings date for LOVE stock?
CANNARA BIOTECH INC (LOVE.CA) last reported earnings on 1/26/2026.
TSX-V:LOVE • CA13765U2002
Past quarterly earnings results for CANNARA BIOTECH INC (LOVE.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in CAD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | - | - | 30.113M | - | 20.11% | |||
| Q4 2025 | - | - | 28.327M | - | 20.86% | |||
| Q3 2025 | - | - | 27.333M | - | 39.85% | |||
| Q2 2025 | - | - | 26.586M | - | 35.07% | |||
| Q1 2025 | - | - | 25.07M | - | 28.68% | |||
| Q4 2024 | - | - | 23.438M | - | 28.23% | |||
| Q3 2024 | - | - | 19.545M | - | 22.64% | |||
| Q2 2024 | - | - | 19.683M | - | 50.99% | |||
| Q1 2024 | - | - | 19.483M | - | 88.95% | |||
| Q4 2023 | - | - | 18.279M | - | 53.00% | |||
| Q3 2023 | - | - | 15.937M | - | 58.36% | |||
| Q2 2023 | - | - | 13.036M | - | 75.63% | |||
| Q1 2023 | - | - | 10.312M | - | 57.08% | |||
| Q4 2022 | - | - | 11.947M | - | 84.32% | |||
| Q3 2022 | - | - | 10.064M | - | 40.57% | |||
| Q2 2022 | - | - | 7.422M | - | 228.74% | |||
| Q1 2022 | - | - | 6.565M | - | 379.80% | |||
| Q4 2021 | - | - | 6.482M | - | 956.68% | |||
| Q3 2021 | - | - | 7.159M | - | 837.20% | |||
| Q2 2021 | - | - | 2.258M | - | 237.79% | |||
| Q1 2021 | - | - | 1.368M | - | 156.55% | |||
| Q4 2020 | - | - | 613.4K | - | - | |||
| Q3 2020 | - | - | 763.9K | - | - | |||
| Q2 2020 | - | - | 668.4K | - | - | |||
| Q1 2020 | - | - | 533.3K | - | - |
Notes
CANNARA BIOTECH INC (LOVE.CA) last reported earnings on 1/26/2026.
CANNARA BIOTECH INC (LOVE.CA) missed EPS estimates and missed revenue estimates in the most recent quarter.